Cargando…

Five questions that need answering when considering the design of clinical trials

Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Timothy, Davies, Hugh, Mansmann, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223595/
https://www.ncbi.nlm.nih.gov/pubmed/25027292
http://dx.doi.org/10.1186/1745-6215-15-286
_version_ 1782343225832374272
author Clark, Timothy
Davies, Hugh
Mansmann, Ulrich
author_facet Clark, Timothy
Davies, Hugh
Mansmann, Ulrich
author_sort Clark, Timothy
collection PubMed
description Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer the research question, and why it is the best approach. It is especially important that researchers explain why the treatment difference sought is worthwhile to patients, and they should reference consultations with the public and patient groups and existing literature. Moreover, the study design should be underpinned by a systematic review of the existing evidence, which should be included in the research protocol. The Health Research Authority in collaboration with partners has published guidance entitled ‘Specific questions that need answering when considering the design of clinical trials’. The guidance will help those designing research and those reviewing it to address key issues.
format Online
Article
Text
id pubmed-4223595
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42235952014-11-08 Five questions that need answering when considering the design of clinical trials Clark, Timothy Davies, Hugh Mansmann, Ulrich Trials Commentary Evidence suggests that research protocols often lack important information on study design, which hinders external review. The study protocol should provide an adequate explanation for why the proposed study methodology is appropriate for the question posed, why the study design is likely to answer the research question, and why it is the best approach. It is especially important that researchers explain why the treatment difference sought is worthwhile to patients, and they should reference consultations with the public and patient groups and existing literature. Moreover, the study design should be underpinned by a systematic review of the existing evidence, which should be included in the research protocol. The Health Research Authority in collaboration with partners has published guidance entitled ‘Specific questions that need answering when considering the design of clinical trials’. The guidance will help those designing research and those reviewing it to address key issues. BioMed Central 2014-07-16 /pmc/articles/PMC4223595/ /pubmed/25027292 http://dx.doi.org/10.1186/1745-6215-15-286 Text en Copyright © 2014 Clark et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Clark, Timothy
Davies, Hugh
Mansmann, Ulrich
Five questions that need answering when considering the design of clinical trials
title Five questions that need answering when considering the design of clinical trials
title_full Five questions that need answering when considering the design of clinical trials
title_fullStr Five questions that need answering when considering the design of clinical trials
title_full_unstemmed Five questions that need answering when considering the design of clinical trials
title_short Five questions that need answering when considering the design of clinical trials
title_sort five questions that need answering when considering the design of clinical trials
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223595/
https://www.ncbi.nlm.nih.gov/pubmed/25027292
http://dx.doi.org/10.1186/1745-6215-15-286
work_keys_str_mv AT clarktimothy fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials
AT davieshugh fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials
AT mansmannulrich fivequestionsthatneedansweringwhenconsideringthedesignofclinicaltrials